Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

90.75 +0.54 (+0.60%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Expert Ratings for Boston Scientific
Via Benzinga
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
Healthcare Stocks Delivering Healthy Returns: 5 Stock Picks Investors Are Keeping On Their Radar
Demand for healthcare and healthcare insurance is projected to see continuous growth over the coming months. 
Via Talk Markets
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. 
Via MarketBeat
Here's How Much $1000 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
14 Analysts Have This to Say About Boston Scientific
Via Benzinga
Here's How Much $100 Invested In Boston Scientific 10 Years Ago Would Be Worth Today
Via Benzinga
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
UnitedHealth's Bad News Hits Insurers, But Surgery Partners Signals Breakout
UNH stock slumped after UnitedHealth said more seniors are getting hip and surgery procedures. That sent Surgery Partners stock soaring. 
Via Investor's Business Daily
3 Sizzling Growth Stocks to Buy for 2023’s Second Half
While some experts expect a recession later this year, here are three high-potential stocks for the second half of 2023. 
Via InvestorPlace
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning 
Via MarketBeat
Exposures COVID-19 Product Safety
Regulatory Hurdles Force Boston Scientific to Opt for Minority Stake in M.I. Tech
Boston Scientific Corporation (NYSE: BSX) is terminating its $230 million plan to buy a majority stake in M.I. Tech, a publicly traded Korean manufacturer and distributor of medical devices for... 
Via Benzinga
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network
$100 Invested In This Stock 15 Years Ago Would Be Worth $400 Today
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $3,800 Today
Via Benzinga
Chart Of The Day: Boston Scientific - Medical Technology
Revenue is expected to grow 9.90% this year and another 8.00% next year. Earnings are estimated to increase by 11.40% this year, and an additional 13.30% next year. 
Via Talk Markets
Shockwave Medical, Fast Grower, In Boston Scientific's Sights?
Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave. 
Via MarketBeat
Topics ETFs
Shockwave Tumbles As Boston Scientific Takeover Talk Reportedly Breaks Down
An analyst says Shockwave would fit into Boston Scientific's cardiovascular portfolio. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Market Rally Wobbles Amid Big Earnings Moves From Microsoft, Meta, Crocs, Cloudflare: Weekly Review
Microsoft, Meta, Cloudflare and Crocs were among the many big movers. 
Via Investor's Business Daily
Morgan Stanley Maintains Overweight Rating for Boston Scientific: Here's What You Need To Know
Via Benzinga
Meta Platforms To Rally Around 67%? Here Are 10 Other Analyst Forecasts For Thursday
Morgan Stanley cut the price target for Old Dominion Freight Line, Inc. (NASDAQ: ODFL) from $339 to $334. Morgan Stanley analyst Ravi Shanker maintained an Equal-Weight rating. Old Dominion shares fell... 
Via Benzinga
Can Boston Scientific Set Another Net High?
Boston Scientific issued a stellar report and gave favorable guidance, but the stock is having difficulty moving higher and may move sideways in the near term. 
Via MarketBeat
Boston Scientific Clocks Strong Q1 Earnings As Elective Surgeries Recover, Boosts FY23 Outlook
Boston Scientific Corp (NYSE: BSX) generated Q1 revenues 
Via Benzinga
Boston Scientific Approaches A Profit-Taking Zone On First-Quarter Beat
The company expects full-year organic sales growth of 8%. 
Via Investor's Business Daily
Nasdaq Futures Surge On Microsoft, Alphabet Earnings Cheer: Analyst Tells Why Investors Might Not 'Sell In May And Go Away'
Stocks could rebound from Tuesday’s steep sell-off, as earnings from Alphabet, Inc. 
Via Benzinga
3 Medtech Companies with Higher Future Share Prices
The analysts see normalization and growth for the med tech industry and have started picking their favorites for 2023 and beyond. 
Via MarketBeat
Why Shockwave Medical Stock Blasted More Than 10% Higher on Friday
The compay might soon be swallowed by a larger rival. 
Via The Motley Fool
Shockwave Rockets As Boston Scientific Reportedly Mulls A Takeover
The deal would help bolster Boston Scientific's cardiovascular portfolio. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.